Chemotherapy: Lo and behold, a role for lomustine in acute myeloid leukemia?
Appelbaum
Frederick R
FR
D000477:Alkylating Agents / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use*; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D008130:Lomustine / Q000627:therapeutic use*; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D016896:Treatment Outcome
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D009607:Nitrosourea Compounds; D003561:Cytarabine; D008130:Lomustine; D015255:Idarubicin